| Suspension - Faron Pharmaceuticals Oy | 30-Mar-2026 | 07:30 | RNS |
| FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY | 12-Mar-2026 | 14:30 | RNS |
| The Finnish Financial Supervisory Authority has ... | 11-Mar-2026 | 18:20 | RNS |
| FARON PHARMACEUTICALS LTD: HOLDING(S) IN COMPANY | 11-Mar-2026 | 08:00 | RNS |
| Inside Information: Faron publishes the terms an... | 10-Mar-2026 | 07:48 | RNS |
| FDA Grants Orphan Drug Designation | 03-Mar-2025 | 12:05 | RNS |
| Notice of Annual General Meeting | 28-Feb-2025 | 12:00 | RNS |
| Positive EMA Opinion on Orphan Drug Designation | 27-Feb-2025 | 07:30 | RNS |
| Annual Report 2024 published | 27-Feb-2025 | 07:15 | RNS |
| Financial Statement 1 January to 31 December 2024 | 27-Feb-2025 | 07:00 | RNS |
| Notice of Financial Statement and Annual Report | 19-Feb-2025 | 10:00 | RNS |
| Holding(s) in Company | 14-Feb-2025 | 12:00 | RNS |
| Change of Broker | 11-Feb-2025 | 07:30 | RNS |
| Holding(s) in Company | 06-Feb-2025 | 15:00 | RNS |
| Results of Oversubscribed Placing | 06-Feb-2025 | 07:00 | RNS |
| Currency | UK Pounds |
| Share Price | 39.60p |
| Change Today | -1.40p |
| % Change | -3.41 % |
| 52 Week High | 246.97 |
| 52 Week Low | 37.00 |
| Volume | 7,365 |
| Shares Issued | 224.35m |
| Market Cap | £88.84m |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 16:35 | 88 @ 39.60p |
| 16:35 | 88 @ 39.60p |
| 16:35 | 88 @ 39.60p |
| 16:35 | 88 @ 39.60p |
| 16:35 | 88 @ 39.60p |
| CEO | Juho Jalkanen |
| Chair | Tuomo Pätsi |
| CFO | Jurriaan Dekkers |
You are here: research